A lot of push and pull on this stock - I guess the push back down is the shorts trying to get out a good price before ZIOP goes to 20 - and this is probably the last few days to do so, and then other good news may come out.
Wow...next time I look to buy a pharma company I best do my due diligence of potential deals that they are considering which looks like a hail mary play to stay in the game - that said, while I think this sell off is due to most thinking 1) they over paid for PCYC significantly - if and that is a big if - that it produces the results that it set out to do so, then it should be able to recover - the only short term recovery I see in this stock is if analysts come out and due an analysis of this deal more thoroughly and conclude that though it was clear over paid, it was necessary to stay in the game ....this was my worst pick of the year - biggest lost in shortest period of time too...
Despite the dovish stance - Bonds are at multi-year highs - TLT is 8 pts away from its high again, and though the cry that negative rates in EUROPE will cause inflow into bond market - I do not see that happening, if best, they will put it in depressed equities first or U.S. global equities first - TLT moved a remarkable 4 points in 3 days - which is nearly unheard of for this ETF movement - if it does attempt a new high, I feel that it may touch 120 first before doing so - could be wrong but that is my analysis. Plus every Bull Bond is out there pushing bonds on the same principle - so too many pushing onto one side sets up typically for a move to the downside first.....remarkable last three days though.
Now that we witnessed pretty much all who is going to sell - and see support around 44-45, you can understand weak hands selling into the close, there is no doubt that G-PRO links up with TWITTER or FB or another social media site - and cross-sells - 44-45 is a good deal - but don't get upset with me when it is back at 80 and you refused to buy in after today's 11% on sale gift.
not sure how it would work - but makes for an interesting combo - or if FB buys it.
Attach your data to this enormous generalization that the vast majority of people in the US have heart disease or will as well as the global population - I am not disagreeing with you, I am saying back up what you say with actual data - then perhaps, EW will meet its number. People can still change and often due to a health scare - regardless of their age in life.
The growth of EW is based on its heart valve product but it also assumes with an aging baby booming populations that all will have some level or a greater level of heart disease. I would be curious to know what if people are not eating as much red meat, or their heart is in better shape, far better, than would require the use of any type of valve - so while the company is indeed interesting, it is banking on the fact that millions of people will eat poorly and end up with heart disease requiring some level of treatment that EW offers. We respectfully disagree. People are far more aware of what they eat, and Americans are getting healthier - in the interim, we would rather look at health company that focuses on stem cell research - that is the way of the future - EW NEEDS people to be ill and poor eaters - and therefore, at this time, we would consider analyst' numbers based on poor eating being a U.S. and global epidemic -- in order for EW or even MDT to make their numbers in their future.